Technical

Technical — The price picture

Blue Moon trades at HK$2.96, barely above its 52-week low and a fraction of the HK$19.16 IPO-era peak. The longer-term trend is broken (death cross September 2025, price below the 200-day), but near-term the tape is turning — price has reclaimed the 50- and 100-day moving averages, MACD histogram is positive, and both 1-month and 3-month returns are up roughly 10%. The question for this section is whether that bounce is a durable base or a relief rally inside a still-intact downtrend.

1. Price snapshot

Beta of 0.11 against the S&P 500 reflects the low correlation between a Hong Kong-listed Chinese consumer name and the US market; read it as a note on benchmark mismatch rather than as evidence of defensiveness.

2. Full-history price — the trend that matters

The full-history chart tells the structural story that shorter windows hide. Blue Moon listed in December 2020 at HK$13.16 and spiked to HK$19.16 inside a month on post-IPO enthusiasm. Everything since has been a five-year de-rating: the stock is down roughly 85% from peak and more than 80% below its IPO price. The 200-day SMA has been a ceiling since mid-2021 with only one brief exception in late 2024. Near-term price action above the 50- and 100-day lines is real, but the line that matters — the 200-day — still sits overhead.

3. Relative strength vs broad market

No sector ETF is available for Hong Kong-listed Chinese household products, so the comparison is to SPY only. This isn't an apples-to-apples read on sector rotation — it's a read on whether global capital allocators who could have held this name were rewarded for doing so. They weren't.

Over three years, SPY is up about 79% while Blue Moon is down 34%. The gap — roughly 113 percentage points — has widened steadily rather than stabilized, and even recent US volatility has not dented the outperformance. For a long-horizon investor, the takeaway is that opportunity cost has been substantial, and the recent bounce in Blue Moon has not closed any of it.

4. Momentum — RSI and MACD

RSI sits at 58 — mid-range, neither overbought nor oversold. The MACD histogram flipped positive in mid-March and has stayed there, with the line above the signal. That's a short-term momentum confirmation of the recent bounce off the HK$2.50 area. Momentum has not crossed into a condition that would signal exhaustion (no 70+ RSI reading, no histogram reversal), so near-term the tape leans constructive. The contradiction: that constructive reading sits inside a broken long-term trend, so it should be treated as a tactical signal with limited scope.

5. Volume & conviction

The three largest volume events all cluster around the two moving-average crosses: September 2024 (near the golden cross) and September 2025 (ahead of the death cross). The 2025-09-18 spike at 22× average volume came with a 7.4% up-day — classic short-squeeze-on-a-downtrend signature, since the trend kept lower within weeks. On a normalized basis, average daily turnover has run near 1.3 million shares recently (roughly HK$4M), meaning this is a thin book — individual catalysts can move price disproportionately, and indicator signals should be weighted accordingly. Beyond the identified spikes, volume has been converging toward its 50-day mean; there is no sign of accumulation confirming the bounce.

6. Volatility regime

At 38% annualized, realized volatility sits between the p20 "calm" band (29%) and the p80 "stressed" band (50%) — roughly the middle of the five-year distribution. The September 2025 spike is visible but vol has reset sharply since. In plain terms: the market is not currently pricing in an imminent regime change, which is consistent with the sideways grind the tape is showing. Vol will matter again if 2.50 breaks to the downside or 3.25 is reclaimed to the upside.

7. Technical scorecard and stance

Six-month stance: neutral-to-bearish. Four of six dimensions are negative or neutral, and the one bullish dimension (short-term momentum) is operating inside a broken long-term trend. This is a trading bounce inside a five-year de-rating, not an inflection. For a long-horizon position, the burden of proof sits with the bulls.